Are there two disjunct episignatures for KMT2B-related disease?
2024

Concerns About KMT2B-related Disease Findings

Sample size: 8 Commentary Evidence: low

Author Information

Author(s): Konrad Oexle

Primary Institution: Institute of Neurogenomics, Helmholtz Munich

Hypothesis

Are there two disjunct episignatures for KMT2B-related disease?

Conclusion

The findings regarding a specific DNA methylation profile in KMT2B-related disease may not be reliable due to potential methodological flaws.

Supporting Evidence

  • Three of the four variants observed were predicted to be likely benign.
  • The specific DNA methylation profile was not selected using a stringent genome-wide significance threshold.
  • The proclaimed methylation profile was not tested in an independent set of affected individuals.

Takeaway

Some researchers found a special pattern in DNA that might help understand a disease, but there are big questions about whether their results are correct.

Methodology

The study analyzed DNA methylation profiles from individuals with KMT2B variants.

Potential Biases

The use of relaxed significance thresholds may lead to false positives.

Limitations

The findings were not validated in an independent set of patients, and some variants were predicted to be benign.

Participant Demographics

Individuals with heterozygous KMT2B missense variants and adult-onset dystonia or non-dystonic phenotypes.

Digital Object Identifier (DOI)

10.1093/braincomms/fcae383

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication